V
ViroGates A/S
CSE:VIRO
ViroGates A/S
CSE:VIRO
Price:
11.85
DKK
-3.66%
Market Cap:
kr110m
Relative Value
The Relative Value of one VIRO stock under the Base Case scenario is 1.49 DKK. Compared to the current market price of 11.85 DKK, ViroGates A/S is Overvalued by 87%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VIRO
Relative Value
Base Case
1.49
DKK
Overvaluation 87%
V
Multiples Across Competitors
VIRO Competitors Multiples
ViroGates A/S Competitors
ViroGates A/S Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DK |
V
|
ViroGates A/S
CSE:VIRO
|
110m DKK | 21.8 | -8.9 | -8.3 | -8.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
198.9B USD | 4.5 | 30.5 | 17.5 | 24 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
176.3B USD | 17.5 | 61.7 | 46.8 | 57.5 | |
| US |
|
Stryker Corp
NYSE:SYK
|
148.2B USD | 5.9 | 45.7 | 23.1 | 27.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
126.2B USD | 3.6 | 27.4 | 14.8 | 21.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
113B USD | 5.6 | 39 | 22.8 | 30.5 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.7B EUR | 2 | 21.7 | 12 | 16.9 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.8B USD | 11.8 | 48 | 34.1 | 37.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.1B USD | 2.3 | 28.5 | 11 | 18.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
50.5B USD | 8.3 | 47 | 26 | 28.4 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
36.6B USD | 1.8 | 17.7 | 12.5 | 15.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
